The US Food and Drug Administration (FDA) has approved AstraZeneca's FluMist, a needle-free nasal spray influenza vaccine for ...

The FDA has approved AstraZeneca's FluMist nasal spray to be used outside of a health care setting. Outside a Trump rally in ...

The Food and Drug Administration (FDA) has approved the first nasal spray flu vaccine which can be administered by the ...

AstraZeneca has just scored big on the quest to make routine vaccinations less of a hassle. | The FDA signed off on ...

FluMist has been sold at pharmacies for years, but now it will be available to use at home as early as next year.

FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...

The EMA CHMP has recommended granting approval for AstraZeneca’s Fasenra for eosinophilic granulomatosis with polyangiitis ...

Next year’s flu season will have an additional option for people looking to protect themselves: a flu vaccine that can be ...

The FDA has approved at-home self- or caregiver-administration of FluMist (influenza vaccine live, intranasal).

AstraZeneca has announced that FluMist has been approved in the US as the self-administered influenza vaccine. FluMist, a ...

Next year’s flu season will have an additional option for people looking to protect themselves: a flu vaccine that can be ...

Holding off until a bit before the holiday is helpful because it takes about 2 weeks for protection to develop after ...